The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early response assessment through multiparametric MRI based endpoints in a phase II multicenter study evaluating the efficacy of DPX-Survivac, intermittent low dose cyclophosphamide (CPA) and pembrolizumab combination study in subjects with solid tumors.
 
Diana Roettger
Employment - ImageIQ
 
Faiq Shaikh
Employment - Cellsight Technologies; Image Analysis Group
Stock and Other Ownership Interests - Cellsight Technologies
Consulting or Advisory Role - Cellsight Technologies; Image Analysis Group
Research Funding - Cellsight Technologies; Image Analysis Group
Other Relationship - Cellsight Technologies; Image Analysis Group
 
Sotirios Bisdas
No Relationships to Disclose
 
Lisa Diana MacDonald
Employment - IMV
Research Funding - IMV
Other Relationship - IMV
 
Stephan Fiset
Employment - IMV
Research Funding - IMV
Other Relationship - IMV
 
Gabriela Nicola Rosu
Employment - Immunovaccine
Leadership - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - I am employed and own stock options in Immunovaccine Inc which owns Depovax and DPX Survivac
Travel, Accommodations, Expenses - Immunovaccine